ANZCA CTN guidelines for endorsement
CTN guidelines for endorsement
Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor Use
Alert update May 2023: Periprocedural diabetic ketoacidosis (DKA) with sodium-glucose co-transporter-2 inhibitor use in people with diabetes.
Letter from Dr Vanessa Bevis to Dr Ashley Bloomfield re NZ vaccination rollout 20210217
Letter from ANZCA President, Dr Vanessa Bevis to Dr Ashley Bloomfield, Director-General, NZ Ministry of Health re the NZ COVID-19 vaccination rollout 20210217
FPM Practice Assessment Pathway Assessment checklist
Use this checklist for endorsement criteria to become endorsed in pain medicine procedures via the practice assessment pathway